Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -11.50 -8.61% 122.00 120.00 120.50 133.00 120.00 133.00 4,200,626 16:35:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -29.4 -36.8 - 160

4d Pharma PLC Block Listing Six Monthly Return

14/09/2020 4:30pm

UK Regulatory (RNS & others)

4d Pharma (LSE:DDDD)
Historical Stock Chart

From Aug 2020 to Oct 2020

Click Here for more 4d Pharma Charts.


RNS Number : 9441Y

4d Pharma PLC

14 September 2020

14 September 2020

4D pharma plc

(the "Company" or "4D")

Block Listing Six Monthly Return

 Name of applicant:                                      4D Pharma plc 
 Name of scheme:                                         Block Admission for February 2020 warrants 
 Period of return:               From:                   10 March 2020            To:       9 September 2020 
                                ----------------------  -----------------------  --------  --------------------------- 
 Number of securities originally admitted at date of     22,000,000 Ordinary Shares of 0.25p each on 10 March 2020 
 Balance of unallotted securities under scheme(s) from   22,000,000 Ordinary shares 
 previous return: 
 Plus: The amount by which the block scheme(s) has       0 Ordinary shares 
 been increased since the date of the last 
 return (if any increase has been applied for): 
 Less: Number of securities issued/allotted under        0 Ordinary shares 
 scheme(s) during period: 
 Equals: Balance under scheme(s) not yet                 22,000,000 Ordinary shares 
 issued/allotted at end of period: 
 Name of contact:               Duncan Peyton 
 Telephone number of contact:   Company Secretary (0113 895 0130) 

Contact Information:


Duncan Peyton, Chief Executive Officer +44 (0)113 895 0130

Investor Relations

N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496 3000

Aubrey Powell / Justin McKeegan / Iqra Amin (Corporate Finance)

Tom Salvesen (Corporate Broking)

Bryan Garnier & Co. Limited - Joint Broker +44 (0)20 7332 2500

Dominic Wilson / Phil Walker

Image Box Communications

Neil Hunter / Michelle Boxall +44 (0)20 8943 4685

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

September 14, 2020 11:30 ET (15:30 GMT)

1 Year 4d Pharma Chart

1 Year 4d Pharma Chart

1 Month 4d Pharma Chart

1 Month 4d Pharma Chart
ADVFN Advertorial
Your Recent History
4d Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201027 05:01:08